nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—CMA1—atopic dermatitis	0.0482	0.12	CbGpPWpGaD
Azilsartan medoxomil—Oedema peripheral—Desonide—atopic dermatitis	0.0142	0.0238	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—FOXP3—atopic dermatitis	0.013	0.0324	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CCR3—atopic dermatitis	0.0121	0.0301	CbGpPWpGaD
Azilsartan medoxomil—Hyperuricaemia—Tacrolimus—atopic dermatitis	0.0119	0.0199	CcSEcCtD
Azilsartan medoxomil—Blood uric acid increased—Tacrolimus—atopic dermatitis	0.0113	0.0188	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL13—atopic dermatitis	0.0111	0.0277	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.0108	0.027	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Desonide—atopic dermatitis	0.0106	0.0178	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CXCR3—atopic dermatitis	0.0106	0.0263	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL17A—atopic dermatitis	0.0102	0.0255	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Desonide—atopic dermatitis	0.0101	0.0168	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Desonide—atopic dermatitis	0.00998	0.0167	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00966	0.024	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL5—atopic dermatitis	0.00952	0.0237	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00866	0.0216	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Fluocinonide—atopic dermatitis	0.00862	0.0144	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Fluocinonide—atopic dermatitis	0.00816	0.0136	CcSEcCtD
Azilsartan medoxomil—Angioedema—Pimecrolimus—atopic dermatitis	0.00812	0.0136	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Fluocinonide—atopic dermatitis	0.00808	0.0135	CcSEcCtD
Azilsartan medoxomil—Blood creatinine increased—Tacrolimus—atopic dermatitis	0.00752	0.0126	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Pimecrolimus—atopic dermatitis	0.00752	0.0126	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00727	0.0181	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Desonide—atopic dermatitis	0.00727	0.0121	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Fluocinolone Acetonide—atopic dermatitis	0.00718	0.012	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.00712	0.0119	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Pimecrolimus—atopic dermatitis	0.00705	0.0118	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00698	0.0174	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL10—atopic dermatitis	0.00696	0.0173	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL4—atopic dermatitis	0.00677	0.0168	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CCR5—atopic dermatitis	0.00663	0.0165	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00648	0.0161	CbGpPWpGaD
Azilsartan medoxomil—Rash—Desonide—atopic dermatitis	0.00648	0.0108	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Desonide—atopic dermatitis	0.00647	0.0108	CcSEcCtD
Azilsartan medoxomil—Angioedema—Loratadine—atopic dermatitis	0.00647	0.0108	CcSEcCtD
Azilsartan medoxomil—Fatigue—Diphenhydramine—atopic dermatitis	0.00647	0.0108	CcSEcCtD
Azilsartan medoxomil—Fatigue—Dimenhydrinate—atopic dermatitis	0.00647	0.0108	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.00626	0.0105	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Loratadine—atopic dermatitis	0.00599	0.01	CcSEcCtD
Azilsartan medoxomil—Pruritus—Fluocinonide—atopic dermatitis	0.00589	0.00984	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00581	0.0145	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00569	0.0142	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Loratadine—atopic dermatitis	0.00567	0.00948	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Loratadine—atopic dermatitis	0.00561	0.00938	CcSEcCtD
Azilsartan medoxomil—Angioedema—Mometasone—atopic dermatitis	0.00555	0.00928	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL22—atopic dermatitis	0.00554	0.0138	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Fluocinonide—atopic dermatitis	0.0055	0.0092	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Tacrolimus—atopic dermatitis	0.00547	0.00915	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Tacrolimus—atopic dermatitis	0.00546	0.00913	CcSEcCtD
Azilsartan medoxomil—Asthenia—Dimenhydrinate—atopic dermatitis	0.00538	0.009	CcSEcCtD
Azilsartan medoxomil—Asthenia—Diphenhydramine—atopic dermatitis	0.00538	0.009	CcSEcCtD
Azilsartan medoxomil—Rash—Fluocinonide—atopic dermatitis	0.00525	0.00877	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Fluocinonide—atopic dermatitis	0.00524	0.00876	CcSEcCtD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.00514	0.0128	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—NPS—atopic dermatitis	0.00514	0.0128	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Diphenhydramine—atopic dermatitis	0.00513	0.00858	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.00513	0.00858	CcSEcCtD
Azilsartan medoxomil—Pruritus—Pimecrolimus—atopic dermatitis	0.00513	0.00858	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.00509	0.00852	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00507	0.0126	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00507	0.0126	CbGpPWpGaD
Azilsartan medoxomil—Angiopathy—Tacrolimus—atopic dermatitis	0.00504	0.00843	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.00499	0.00834	CcSEcCtD
Azilsartan medoxomil—Fatigue—Loratadine—atopic dermatitis	0.00498	0.00833	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00498	0.0124	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00496	0.0083	CcSEcCtD
Azilsartan medoxomil—Dizziness—Diphenhydramine—atopic dermatitis	0.00496	0.0083	CcSEcCtD
Azilsartan medoxomil—Dizziness—Dimenhydrinate—atopic dermatitis	0.00496	0.0083	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL27—atopic dermatitis	0.00493	0.0123	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK8—atopic dermatitis	0.00483	0.012	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CASP8—atopic dermatitis	0.00481	0.012	CbGpPWpGaD
Azilsartan medoxomil—Rash—Dimenhydrinate—atopic dermatitis	0.00473	0.00791	CcSEcCtD
Azilsartan medoxomil—Rash—Diphenhydramine—atopic dermatitis	0.00473	0.00791	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Dimenhydrinate—atopic dermatitis	0.00473	0.0079	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Diphenhydramine—atopic dermatitis	0.00473	0.0079	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00468	0.0117	CbGpPWpGaD
Azilsartan medoxomil—Muscle spasms—Tacrolimus—atopic dermatitis	0.00465	0.00777	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.0046	0.0114	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.0046	0.0114	CbGpPWpGaD
Azilsartan medoxomil—Rash—Pimecrolimus—atopic dermatitis	0.00457	0.00765	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Pimecrolimus—atopic dermatitis	0.00457	0.00764	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00448	0.0075	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00446	0.0111	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Dimenhydrinate—atopic dermatitis	0.00446	0.00745	CcSEcCtD
Azilsartan medoxomil—Nausea—Diphenhydramine—atopic dermatitis	0.00446	0.00745	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL17—atopic dermatitis	0.00443	0.011	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Pimecrolimus—atopic dermatitis	0.00431	0.00721	CcSEcCtD
Azilsartan medoxomil—Fatigue—Mometasone—atopic dermatitis	0.00428	0.00715	CcSEcCtD
Azilsartan medoxomil—Asthenia—Loratadine—atopic dermatitis	0.00415	0.00693	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IFNG—atopic dermatitis	0.00409	0.0102	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.00409	0.00684	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00402	0.01	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Loratadine—atopic dermatitis	0.00395	0.00661	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.0039	0.0097	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Tacrolimus—atopic dermatitis	0.00387	0.00647	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Tacrolimus—atopic dermatitis	0.00383	0.00641	CcSEcCtD
Azilsartan medoxomil—Dizziness—Loratadine—atopic dermatitis	0.00382	0.00639	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—atopic dermatitis	0.00382	0.00951	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00382	0.0095	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CXCL8—atopic dermatitis	0.00381	0.00947	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.00367	0.00614	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL1B—atopic dermatitis	0.00365	0.00909	CbGpPWpGaD
Azilsartan medoxomil—Rash—Loratadine—atopic dermatitis	0.00364	0.00609	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Loratadine—atopic dermatitis	0.00364	0.00609	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL2—atopic dermatitis	0.00364	0.00905	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL11—atopic dermatitis	0.00357	0.00888	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Mometasone—atopic dermatitis	0.00356	0.00595	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00355	0.00594	CcSEcCtD
Azilsartan medoxomil—Pruritus—Mometasone—atopic dermatitis	0.00351	0.00587	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00346	0.00862	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00343	0.00574	CcSEcCtD
Azilsartan medoxomil—Nausea—Loratadine—atopic dermatitis	0.00343	0.00574	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.00341	0.0057	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.00341	0.00569	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.0034	0.00847	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.0034	0.00847	CbGpPWpGaD
Azilsartan medoxomil—Fatigue—Tacrolimus—atopic dermatitis	0.0034	0.00569	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Mometasone—atopic dermatitis	0.00339	0.00567	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00334	0.00831	CbGpPWpGaD
Azilsartan medoxomil—Rash—Fluocinolone Acetonide—atopic dermatitis	0.00327	0.00547	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.00327	0.00547	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.0032	0.00535	CcSEcCtD
Azilsartan medoxomil—Rash—Mometasone—atopic dermatitis	0.00313	0.00523	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Mometasone—atopic dermatitis	0.00312	0.00522	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00312	0.00776	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00309	0.00516	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Methylprednisolone—atopic dermatitis	0.00295	0.00494	CcSEcCtD
Azilsartan medoxomil—Nausea—Mometasone—atopic dermatitis	0.00295	0.00493	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR3—atopic dermatitis	0.00291	0.00724	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL22—atopic dermatitis	0.00284	0.00707	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Tacrolimus—atopic dermatitis	0.00283	0.00473	CcSEcCtD
Azilsartan medoxomil—Angioedema—Prednisolone—atopic dermatitis	0.00282	0.00472	CcSEcCtD
Azilsartan medoxomil—Pruritus—Tacrolimus—atopic dermatitis	0.00279	0.00467	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00279	0.00694	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Hydrocortisone—atopic dermatitis	0.00276	0.00461	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Tacrolimus—atopic dermatitis	0.0027	0.00452	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.0027	0.00671	CbGpPWpGaD
Azilsartan medoxomil—Angiopathy—Dexamethasone—atopic dermatitis	0.00269	0.00449	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Betamethasone—atopic dermatitis	0.00269	0.00449	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TNF—atopic dermatitis	0.00265	0.00659	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Tacrolimus—atopic dermatitis	0.00261	0.00436	CcSEcCtD
Azilsartan medoxomil—Angioedema—Triamcinolone—atopic dermatitis	0.0026	0.00434	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—TAC1—atopic dermatitis	0.00259	0.00645	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—NPS—atopic dermatitis	0.00259	0.00645	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Methylprednisolone—atopic dermatitis	0.00259	0.00433	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.00255	0.00426	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00254	0.00633	CbGpPWpGaD
Azilsartan medoxomil—Connective tissue disorder—Prednisone—atopic dermatitis	0.00253	0.00424	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL27—atopic dermatitis	0.00253	0.0063	CbGpPWpGaD
Azilsartan medoxomil—Rash—Tacrolimus—atopic dermatitis	0.00249	0.00416	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Tacrolimus—atopic dermatitis	0.00249	0.00416	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00244	0.00608	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.00241	0.00404	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.0024	0.00401	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Hydrocortisone—atopic dermatitis	0.00239	0.004	CcSEcCtD
Azilsartan medoxomil—Angioedema—Dexamethasone—atopic dermatitis	0.00236	0.00394	CcSEcCtD
Azilsartan medoxomil—Angioedema—Betamethasone—atopic dermatitis	0.00236	0.00394	CcSEcCtD
Azilsartan medoxomil—Nausea—Tacrolimus—atopic dermatitis	0.00234	0.00392	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Prednisone—atopic dermatitis	0.00234	0.00391	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00232	0.00578	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL17—atopic dermatitis	0.00227	0.00565	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.00227	0.00379	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Methylprednisolone—atopic dermatitis	0.00225	0.00376	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.00213	0.00355	CcSEcCtD
Azilsartan medoxomil—Fatigue—Hydrocortisone—atopic dermatitis	0.00212	0.00355	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00209	0.00521	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Dexamethasone—atopic dermatitis	0.00206	0.00345	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Betamethasone—atopic dermatitis	0.00206	0.00345	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL10—atopic dermatitis	0.00205	0.00511	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Prednisone—atopic dermatitis	0.00205	0.00343	CcSEcCtD
Azilsartan medoxomil—Fatigue—Triamcinolone—atopic dermatitis	0.002	0.00334	CcSEcCtD
Azilsartan medoxomil—Fatigue—Methylprednisolone—atopic dermatitis	0.00199	0.00333	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.0019	0.00317	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00189	0.00469	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL11—atopic dermatitis	0.00183	0.00456	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.00182	0.00304	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.00182	0.00304	CcSEcCtD
Azilsartan medoxomil—Fatigue—Dexamethasone—atopic dermatitis	0.00181	0.00303	CcSEcCtD
Azilsartan medoxomil—Fatigue—Betamethasone—atopic dermatitis	0.00181	0.00303	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FCER2—atopic dermatitis	0.00181	0.00449	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Prednisone—atopic dermatitis	0.0018	0.003	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Prednisone—atopic dermatitis	0.00178	0.00298	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL5—atopic dermatitis	0.00177	0.0044	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Hydrocortisone—atopic dermatitis	0.00177	0.00295	CcSEcCtD
Azilsartan medoxomil—Pruritus—Hydrocortisone—atopic dermatitis	0.00174	0.00291	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Hydrocortisone—atopic dermatitis	0.00168	0.00282	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL22—atopic dermatitis	0.00168	0.00418	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Prednisolone—atopic dermatitis	0.00167	0.00279	CcSEcCtD
Azilsartan medoxomil—Asthenia—Triamcinolone—atopic dermatitis	0.00166	0.00278	CcSEcCtD
Azilsartan medoxomil—Asthenia—Methylprednisolone—atopic dermatitis	0.00166	0.00277	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR3—atopic dermatitis	0.00164	0.00409	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Triamcinolone—atopic dermatitis	0.00164	0.00274	CcSEcCtD
Azilsartan medoxomil—Pruritus—Methylprednisolone—atopic dermatitis	0.00164	0.00274	CcSEcCtD
Azilsartan medoxomil—Dizziness—Hydrocortisone—atopic dermatitis	0.00163	0.00272	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR5—atopic dermatitis	0.00159	0.00397	CbGpPWpGaD
Azilsartan medoxomil—Rash—Prednisolone—atopic dermatitis	0.00159	0.00266	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Prednisolone—atopic dermatitis	0.00159	0.00266	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Methylprednisolone—atopic dermatitis	0.00158	0.00265	CcSEcCtD
Azilsartan medoxomil—Fatigue—Prednisone—atopic dermatitis	0.00158	0.00264	CcSEcCtD
Azilsartan medoxomil—Rash—Hydrocortisone—atopic dermatitis	0.00155	0.0026	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Hydrocortisone—atopic dermatitis	0.00155	0.00259	CcSEcCtD
Azilsartan medoxomil—Dizziness—Triamcinolone—atopic dermatitis	0.00153	0.00256	CcSEcCtD
Azilsartan medoxomil—Dizziness—Methylprednisolone—atopic dermatitis	0.00153	0.00256	CcSEcCtD
Azilsartan medoxomil—Asthenia—Betamethasone—atopic dermatitis	0.00151	0.00252	CcSEcCtD
Azilsartan medoxomil—Asthenia—Dexamethasone—atopic dermatitis	0.00151	0.00252	CcSEcCtD
Azilsartan medoxomil—Nausea—Prednisolone—atopic dermatitis	0.0015	0.0025	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL27—atopic dermatitis	0.0015	0.00372	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR3—atopic dermatitis	0.00149	0.00371	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Betamethasone—atopic dermatitis	0.00149	0.00249	CcSEcCtD
Azilsartan medoxomil—Pruritus—Dexamethasone—atopic dermatitis	0.00149	0.00249	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPS—atopic dermatitis	0.00146	0.00365	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—TAC1—atopic dermatitis	0.00146	0.00365	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Hydrocortisone—atopic dermatitis	0.00146	0.00245	CcSEcCtD
Azilsartan medoxomil—Rash—Triamcinolone—atopic dermatitis	0.00146	0.00244	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Triamcinolone—atopic dermatitis	0.00146	0.00244	CcSEcCtD
Azilsartan medoxomil—Rash—Methylprednisolone—atopic dermatitis	0.00146	0.00244	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Methylprednisolone—atopic dermatitis	0.00146	0.00244	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Dexamethasone—atopic dermatitis	0.00144	0.00241	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Betamethasone—atopic dermatitis	0.00144	0.00241	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00144	0.00357	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Dexamethasone—atopic dermatitis	0.00139	0.00233	CcSEcCtD
Azilsartan medoxomil—Dizziness—Betamethasone—atopic dermatitis	0.00139	0.00233	CcSEcCtD
Azilsartan medoxomil—Nausea—Triamcinolone—atopic dermatitis	0.00138	0.0023	CcSEcCtD
Azilsartan medoxomil—Nausea—Methylprednisolone—atopic dermatitis	0.00137	0.0023	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL5—atopic dermatitis	0.00136	0.00339	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL17—atopic dermatitis	0.00134	0.00334	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—TAC1—atopic dermatitis	0.00133	0.00331	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPS—atopic dermatitis	0.00133	0.00331	CbGpPWpGaD
Azilsartan medoxomil—Rash—Dexamethasone—atopic dermatitis	0.00133	0.00222	CcSEcCtD
Azilsartan medoxomil—Rash—Betamethasone—atopic dermatitis	0.00133	0.00222	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Dexamethasone—atopic dermatitis	0.00133	0.00222	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Betamethasone—atopic dermatitis	0.00133	0.00222	CcSEcCtD
Azilsartan medoxomil—Asthenia—Prednisone—atopic dermatitis	0.00131	0.0022	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCR3—atopic dermatitis	0.0013	0.00325	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Prednisone—atopic dermatitis	0.0013	0.00217	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.00127	0.00315	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Prednisone—atopic dermatitis	0.00125	0.0021	CcSEcCtD
Azilsartan medoxomil—Nausea—Dexamethasone—atopic dermatitis	0.00125	0.00209	CcSEcCtD
Azilsartan medoxomil—Nausea—Betamethasone—atopic dermatitis	0.00125	0.00209	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL5—atopic dermatitis	0.00124	0.00308	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Prednisone—atopic dermatitis	0.00121	0.00203	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—KIF3A—atopic dermatitis	0.0012	0.00298	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00116	0.00289	CbGpPWpGaD
Azilsartan medoxomil—Rash—Prednisone—atopic dermatitis	0.00116	0.00193	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Prednisone—atopic dermatitis	0.00115	0.00193	CcSEcCtD
Azilsartan medoxomil—Nausea—Prednisone—atopic dermatitis	0.00109	0.00182	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CMA1—atopic dermatitis	0.00108	0.00269	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL11—atopic dermatitis	0.00108	0.00269	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL10—atopic dermatitis	0.00105	0.00262	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—STAT6—atopic dermatitis	0.00102	0.00253	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000999	0.00249	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000963	0.0024	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.00096	0.00239	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL5—atopic dermatitis	0.000908	0.00226	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR5—atopic dermatitis	0.0009	0.00224	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR3—atopic dermatitis	0.000882	0.00219	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR5—atopic dermatitis	0.000818	0.00203	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPS—atopic dermatitis	0.000786	0.00196	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TAC1—atopic dermatitis	0.000786	0.00196	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCR3—atopic dermatitis	0.000771	0.00192	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL5—atopic dermatitis	0.000731	0.00182	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL10—atopic dermatitis	0.000623	0.00155	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000544	0.00135	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL5—atopic dermatitis	0.000536	0.00133	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL2—atopic dermatitis	0.00052	0.00129	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NGF—atopic dermatitis	0.000497	0.00124	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000494	0.00123	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR5—atopic dermatitis	0.000483	0.0012	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL2—atopic dermatitis	0.000472	0.00118	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NFKBIA—atopic dermatitis	0.00041	0.00102	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL8—atopic dermatitis	0.000292	0.000727	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL2—atopic dermatitis	0.000279	0.000695	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6—atopic dermatitis	0.000278	0.000691	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MAPK8—atopic dermatitis	0.000257	0.000639	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6—atopic dermatitis	0.000164	0.000408	CbGpPWpGaD
